News

Becomes First Hospital in Europe to Operate Two Niobe(R) Systems for Clinical Procedures Stereotaxis, Inc. and Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France, announced the installation of the hospital's second Niobe® remote...

Studies Validate Safety of BIOTRONIK ProMRI Devices in Patients Subjected to Head and Lower Lumbar 1.5 T MRI Scans   BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that its ProMRI and ProMRI AFFIRM...

The American Heart Association/American Stroke Association (AHA/ASA) and Medtronic plc announced a collaboration to reduce the rate of recurrent strokes in the U.S. The two organizations will work together over several years to educate, raise...

First U.S. Patients Enrolled in International Trial to Evaluate Implanted Defibrillator that Offers Protection with Less Risk to the Heart The Valley Hospital has been selected as the United States Coordinating Center for the PRAETORIAN...

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced that it has received approval from Japan’s Pharmaceutical and Medical Devices Agency (PMDA) for its new KORA 100 pacing system...

Medtronic plc announced the initiation of the Cryo4 Persistent AF (Cryoballoon Ablation for Early Persistent Atrial Fibrillation) clinical trial. The trial will evaluate the 12-month clinical outcomes of cryoballoon ablation for isolating the...

The U.S. Food and Drug Administration announced that it will strengthen its review of automated external defibrillators (AEDs) to help improve the quality and reliability of these devices. The FDA issued a final order that will require AED...

AliveCor, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the company clearance for two new algorithms giving users instant feedback on their electrocardiogram (ECG) recordings and expanding its automated...

Medtronic plc announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm. The data show that treating patients with Medtronic implantable cardiac devices equipped with SmartShock™...

Abiomed Inc., a leading provider of breakthrough heart support technologies, announced that the Impella RP® (Right Percutaneous) System has received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE)....